These 3 Struggling Biotechs Could Experience Spring Bumps

When it comes to the three biotech stocks featured in today’s article, all of which have experienced recent struggles, the author notes that their management teams and shareholders alike are hoping that spring announcements related to key drug development programs will serve as catalysts to get their share prices moving back toward previous highs. For these three biotech stocks to consider for spring 2021, CLICK HERE.